107 related articles for article (PubMed ID: 12205536)
1. [Influence of hypertension on the incidence of end-stage renal disease in negroes and mulattoes with glomerulonephritis].
Lopes AA; Silveira MA; Martinelli R; Noblat AC
Rev Assoc Med Bras (1992); 2002; 48(2):167-71. PubMed ID: 12205536
[TBL] [Abstract][Full Text] [Related]
2. [Association between race and incidence of end-stage renal disease secondary to glomerulonephritis: influence of the histologic type and presence of arterial hypertension].
Lopes AA; Silveira MA; Martinelli RP; Rocha H
Rev Assoc Med Bras (1992); 2001; 47(1):78-84. PubMed ID: 11340455
[TBL] [Abstract][Full Text] [Related]
3. [Racial differences between patients with focal segmental glomerulosclerosis and membranoproliferative glomerulonephritis from the State of Bahia].
Lopes AA; Martinelli RP; Silveira MA; Rocha H
Rev Assoc Med Bras (1992); 1999; 45(2):115-20. PubMed ID: 10413913
[TBL] [Abstract][Full Text] [Related]
4. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
[TBL] [Abstract][Full Text] [Related]
5. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of hypertensive end-stage renal disease: effect of patient's race.
Perneger TV; Whelton PK; Klag MJ; Rossiter KA
Am J Epidemiol; 1995 Jan; 141(1):10-5. PubMed ID: 7801960
[TBL] [Abstract][Full Text] [Related]
7. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
8. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.
Ruggenenti P; Perna A; Gherardi G; Benini R; Remuzzi G
Am J Kidney Dis; 2000 Jun; 35(6):1155-65. PubMed ID: 10845831
[TBL] [Abstract][Full Text] [Related]
9. [Systemic arterial hypertension in primary chronic glomerulonephritis: prevalence and its influence on the renal prognosis].
Quirós PL; Ceballos M; Remón C; Hernández Romero MC; Benavides B; Pérez Pérez-Ruilópez MA; Lozano A; Aznar E; Rivero M; Fernández Ruiz E
Nefrologia; 2005; 25(3):250-7. PubMed ID: 16053006
[TBL] [Abstract][Full Text] [Related]
10. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
Batista PB; Lopes AA; Costa FA
Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
[TBL] [Abstract][Full Text] [Related]
11. Report from the Caribbean renal registry, 2006.
Soyibo AK; Barton EN
West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742
[TBL] [Abstract][Full Text] [Related]
12. Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study.
Kwon S; Lee SR; Choi EK; Jung JH; Han KD; Oh S; Lip GYH
Clin Res Cardiol; 2022 Mar; 111(3):284-293. PubMed ID: 34216251
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon.
Halle MP; Takongue C; Kengne AP; Kaze FF; Ngu KB
BMC Nephrol; 2015 Apr; 16():59. PubMed ID: 25896605
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
[TBL] [Abstract][Full Text] [Related]
16. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
Ward MM; Studenski S
Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
[TBL] [Abstract][Full Text] [Related]
17. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: a population-based study.
O'Dea DF; Murphy SW; Hefferton D; Parfrey PS
Am J Kidney Dis; 1998 Nov; 32(5):794-801. PubMed ID: 9820449
[TBL] [Abstract][Full Text] [Related]
18. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates of hypertensive end-stage renal disease.
Bleyer AJ; Chen R; D'Agostino RB; Appel RG
Am J Kidney Dis; 1998 Jan; 31(1):28-34. PubMed ID: 9428448
[TBL] [Abstract][Full Text] [Related]
20. End-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population.
Sim JJ; Bhandari SK; Batech M; Hever A; Harrison TN; Shu YH; Kujubu DA; Jonelis TY; Kanter MH; Jacobsen SJ
Mayo Clin Proc; 2018 Feb; 93(2):167-178. PubMed ID: 29395351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
